- Advertisement -

ARCHIVE

Monthly Archives: May, 2021

Scientific insight into the future of psychedelics

May 2021 marks the second anniversary of establishing the world’s first dedicated center for research into the action and clinical use of psychedelic compounds...

These Psychedelic Patents Could Be The Turning Point For A Medical Breakthrough

Recent efforts to legalize psychedelics for medical and recreational purposes have intensified after the legalization of drugs under Schedule I controlled substances designated by...

Psychedelic Testing to be Conducted by Mycotopia Therapies and Natural MedTech Joint Venture

Mycotopia Therapies, a company focused on psychedelic therapy, has recently announced the formation of ‘PsyBioMed-Australia,’ a joint venture between itself and Natural MedTech. Through...

Algernon Pharmaceuticals Announces its Addition to the Market’s First Psychedelic Stock Index ETF

Vancouver-based clinical-stage pharmaceutical company Algernon Pharmaceuticals was recently added to the Horizons Psychedelic Stock Index ETF (PSYK) in the index’s first quarterly rebalance of...

Peter Thiel-backed Magic Mushroom firm Atai is now worth a whopping $2 billion

German biotech company Atai Life Sciences is all set to become one of the first licensed producers of psilocybin and other psychoactive medicinal substances...

Psychedelic for meth users: Sydney trial aims to conquer addiction

A historical clinical trial being conducted in Sydney can essentially pave the way for psychedelic medicine to seep into the mainstream. The trial aims...

Numinus Bioscience announces 7,500 square foot expansion to its Nanaimo BC Lab

By late 2021, Numinus Bioscience plans to add 7,500 square feet to their state-of-the-art lab in Nanaimo BC in order to accelerate intellectual property development and...

COMPASS Pathways Announces It Has Been Granted Two Psilocybin-Related US Patents

In a press release dated March 23rd, 2021, UK company COMPASS Pathways announced two new US patents related to the formulation and administration of...

Psychedelic Testing to be Conducted by Mycotopia Therapies and Natural MedTech Joint Venture

Mycotopia Therapies, a company focused on psychedelic therapy, has recently announced the formation of ‘PsyBioMed-Australia,’ a joint venture between itself and Natural MedTech. Through...

Latest news

- Advertisement -
COMPASS Pathways Plc - American  CMPS 
$35.81  -3.14%  
   
$0.0000  0.00%  
MIND MEDICINE (MINDMED) INC.  MMED.NE 
$3.89  1.04%  
TrypTherapeutic  TRYP.CN 
$0.6200  5.08%  
AionTherapeutic  AION.CN 
$0.0800  6.67%  
BetterPlantSci  PLNT.CN 
$0.0650  8.33%  
CaptivaVerde  PWR.CN 
$0.1800  0.00%  
   
$0.0000  0.00%  
CodebaseVent  CODE.CN 
$0.1300  0.00%  
CoreOneLabs  COOL.CN 
$5.30  -1.85%  
CYBIN INC.  CYBN.NE 
$3.36  -15.37%  
EGFThera  TMED.CN 
$0.0650  -7.14%  
EHAVE INC  EHVVF 
$0.0410  7.89%  
EmpowerClinInc  CBDT.CN 
$0.4750  -3.06%  
Entheon Biomed  ENBI.CN 
$0.3300  0.00%  
GLOBAL TRAC SOLUTIONS INC  PSYC 
$0.0108  -1.82%  
GraphBlockInc  GBLC.CN 
$0.0650  0.00%  
HAVNLifeSci  HAVN.CN 
$0.4200  10.53%  
HOLLISTER BIOSCIENCES INC  HSTRF 
$0.2013  -6.59%  
LobeSciences  LOBE.CN 
$0.0850  0.00%  
MindCureHealth  MCUR.CN 
$0.4300  2.38%  
MindsetPharma  MSET.CN 
$0.6100  5.17%  
MINERCO INC  MINE 
$0.0003  0.00%  
MYDECINE INNOVATIONS GROUP INC  MYCOF 
$0.3732  -1.79%  
NEONMIND BIOSCIENCES INC  NMDBF 
$0.1176  10.94%  
NEW WAVE HLDGS CORP  TRMNF 
$0.5800  7.35%  
NovaMentisLife  NOVA.CN 
$0.1350  0.00%  
Novamind Inc.  NM.CN 
$1.00  -1.96%  
NUMINUS WELLNESS INC  NUMI.V 
$0.9800  6.52%  
NutritionalHi  EAT.CN 
$0.0150  0.00%  
Pharmadrug  BUZZ.CN 
$0.0600  -7.69%  
PsyenceGroup  PSYG.CN 
$0.1800  -2.70%  
RED LIGHT HOLLAND CORP  TRUFF 
$0.2164  -1.10%  
REVIVE THERAPEUTICS LTD  RVVTF 
$0.4121  -2.71%  
ROADMAN INVESTMENTS CORP  LITT.V 
$0.0400  14.29%  
Seelos Therapeutics, Inc.  SEEL 
$2.38  3.48%  
SILO PHARMA INC  SILO 
$0.1765  5.69%  
THOUGHTFUL BRANDS INC  PEMTF 
$0.1000  -10.71%  
WUHAN GENERAL GROUP CHINA INC  WUHN 
$0.5786  0.00%  
PharmaTher  PHRM.CN 
$1.12  1.82%  
OptimiHealth  OPTI.CN 
$0.7400  0.00%